Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro

Scandinavian Journal of Immunology

Volumn 59, Issue 5, 2004, Pages 425-431

  Kaur, S ^a   Singh, P P ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCAN SYNTHASE; SERUM AMYLOID P;

ACIDITY; ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGLYCOSYLATION; DRUG EFFECT; GROWTH INHIBITION; IN VITRO STUDY; INCUBATION TIME; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN PURIFICATION; REACTION TIME; TEMPERATURE DEPENDENCE;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; SERUM AMYLOID P-COMPONENT;

EID: 2642537706     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01412.x     Document Type: Article

References (43)

1. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
2. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
3. Pepys MB, Baltz ML, Gomer AS. Serum amyloid P-component is an acute phase reactant in the mouse. Nature 1979;278:259-62.
4. Mortensen RF, Beisel K, Zeleznik NJ, Le PT. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol 1983;130:885-9.
5. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive and related proteins (Pentraxins) and serum amyloid A protein. Adv Immunol 1983;34:141-212.
6. Osmand AP, Friedenson B, Gewurz H, Painter RH, Hofmann T, Shelton E. Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci USA 1977;74:739-43.
7. Baltz ML, deBeer FC, Feinstein A et al. Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci 1982;389:49-75.
8. Baltz ML, Dyck RF, Pepys MB. Amyloid P-component in mice injected with casein. identification in amyloid deposits and in the cytoplasm of hepatocytes. Immunology 1980;41:59.
9. deBeer FC, Baltz ML, Holford S, Feinstein A, Pepys MB. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med 1981;154:1134-49.
10. Pepys MB, Butler PJ. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem Biophys Res Commun 1987;148:308-13.
11. Hind CR, Collins PM, Renn D et al. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J Exp Med 1984;1:1058-69.
12. Pepys MB, Booth DR, Hutchinson WL. Amyloid P component. A critical review. Int J Exp Clin Invest 1997;4:274-95.
13. Siripont J, Tebo JM, Mortensen RF. Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component (SAP) to macrophages. Cell Immunol 1988;117:239-52.
14. Sarlo KT, Mortensen RF. Enhanced interleukin 1 (IL-1) production mediated by mouse serum amyloid P component. Cell Immunol 1985;93:398-405.
15. Singh S, Singh PP. Serum amyloid P-component-induced colony-stimulating factors production by macrophages. Scand J Immunol 2001;53:155-61.
16. Singh PP, Gervais F, Skamene E, Mortensen RF. Serum amyloid P-component-induced enhancement of macrophage listericidal activity. Infect Immun 1986;52:688-94.
17. Noursadeghi M, Bickerstaff MCM, Gallimore JR, Herbert J, Cohen J, Pepys MB. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc Natl Acad Sci USA 2000;97:14584-9.
18. Haas CJD, Leeuwen EMMV, Bommel TV, Verhoef J, Kessel KPMV, Strijp JAGV. Serum amyloid P component bound to gram-negative bactreia prevents lipopolysaccharide-mediated classical pathway complement activation. Infect Immun 2000;68:1753-9.
19. WHO. Tuberculosis Fact Sheet no. 104, 2000.
20. Friedland JS, Hartley JC, Hartley CGC, Shattock RJ, Griffin GE. Cytokine secretion in vivo and ex vivo following chemotherapy of Mycobacterium tuberculosis infection. Trans R Soc Trop Med Hyg 1996;90:199-203.
21. N'Diaye EN, Darzacq X, Astarie-Dequeker C, Daffe M, Calafat J, Maridonneau-Parini I. Fusion of azurophil granules with phagosomes and activation of the tyrosine-kinase Hck are specifically inhibited during phagocytosis of mycobacteria by human neutrophils. J Immunol 1998;161:4983-91.
22. Pasula R, Wisniowski P, Martin WJ. Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages. Infect Immun 2002;70:1287-92.
23. Shepherd VL, Freeze HH, Miller AL, Stahl PD. Identification of mannose 6-phosphate receptors in rabbit alveolar macrophages. J Biol Chem 1984;259:2257-61.
24. deBeer FC, Nel AE, Gie RP, Donald PR, Strachan AF. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax 1984;39:196-200.
25. Kaufmann SHE. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001;1:20-30.
26. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993;150:2920-30.
27. Stokes RW, Haidl ID, Jefferies WA, Speert DP. Mycobacteria-macrophage interactions: macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 1993;151:7067-76.
28. Cywes C, Hoppe HC, Daffe M, Ehlers MR. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun 1997;65:4258-66.
29. El-Etr SH, Cirillo JD. Entry mechanisms of mycobacteria. Front Biosci 2001;6:d737-d47.
30. Ortalo-Magne A, Lemassu A, Laneelle M et al. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol 1996;178:456-61.
31. Figura KV, Haslik A. Lysosomal enzymes and their receptors. Annu Rev Biochem 1986;55:167-93.
32. Dahms NM, Lobel P, Breitmeyer J, Chirgwin JM, Kornfeld S. 46 kd mannose 6-phosphate receptor: cloning, expression, and homology to the 215 kd mannose 6- phosphate receptor. Cell 1987;50:181-92.
33. Ezekowitz R, Gordon S. Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guerin-activated mouse macrophages. Role of T lymphocytes and lymphokines. J Exp Med 1982;155:1623-37.
34. Mold C, Gresham HD, Clos TWD. Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs. J Immunol 2001;166:1200-5.
35. Fenton MJ, Vermeulen MW. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996;64:683-90.
36. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
37. Andersen O, Ravn KV, Sorensen IJ, Jonson G, Nielsen EH, Svehag SE. Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro. Scand J Immunol 1997;46:331-7.
38. Horvath A, Andersen I, Junker K et al. Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies. Antiviral Res 2001;52:43-53.
39. Taylor-Robinson AW. Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection. Parasirol Int 2000;48:297-301.
40. Lin B, Ku N, Zahedi K, Whitehead AS, Mortensen RF. IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP). Inflammation 1990;14:297-313.
41. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988;18:717.
42. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SHE. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997;65:4843-9.
43. Nelson SR, Sethi GA, Gower PE, Ballardie FW, Matayakul-Chantler SA, Pepys MB. Serum amyloid P component in chronic renal failure and dialysis. Clin Chim Acta 1991;200:191-200.